Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2425431
Max Phase: Preclinical
Molecular Formula: C30H38F3N5O8
Molecular Weight: 539.63
Molecule Type: Small molecule
Associated Items:
ID: ALA2425431
Max Phase: Preclinical
Molecular Formula: C30H38F3N5O8
Molecular Weight: 539.63
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(CC(=O)N[C@@H](Cc1ccccc1)C(=O)NCCO)C(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C28H37N5O6.C2HF3O2/c1-32(18-25(36)31-23(26(37)30-13-15-34)17-19-6-3-2-4-7-19)28(39)24-8-5-14-33(24)27(38)22(29)16-20-9-11-21(35)12-10-20;3-2(4,5)1(6)7/h2-4,6-7,9-12,22-24,34-35H,5,8,13-18,29H2,1H3,(H,30,37)(H,31,36);(H,6,7)/t22-,23-,24-;/m0./s1
Standard InChI Key: FXXNJMVPYIDPGV-NYTZCTPBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 539.63 | Molecular Weight (Monoisotopic): 539.2744 | AlogP: -0.45 | #Rotatable Bonds: 12 |
Polar Surface Area: 165.30 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.50 | CX Basic pKa: 7.72 | CX LogP: -0.66 | CX LogD: -1.02 |
Aromatic Rings: 2 | Heavy Atoms: 39 | QED Weighted: 0.24 | Np Likeness Score: -0.53 |
1. Mollica A, Costante R, Stefanucci A, Pinnen F, Luisi G, Pieretti S, Borsodi A, Bojnik E, Benyhe S.. (2013) Hybrid peptides endomorphin-2/DAMGO: design, synthesis and biological evaluation., 68 [PMID:23974016] [10.1016/j.ejmech.2013.07.044] |
Source(1):